BW

Bo Wang, MD

Latest Videos

Panel discussion on toxicity, patient selection, and future of Ivonescimab with Dr. Bo Wang, Dr. Benjamin P. Levy, and Dr. Jarushka Naidoo.

HARMONi-6

06/23/2026

Balancing Efficacy and Safety: Toxicity, Patient Selection, and the Future of Ivonescimab

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Diverse group of medical professionals discussing gender representation and applicability of HARMONi-6 findings in oncology research.

HARMONi-6

06/22/2026

Gender Representation and Global Applicability of the HARMONi-6 Findings

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Image from OncUpdates showing Dr. Bo Wang, Dr. Benjamin P. Levy, and Dr. Jarushka Naidoo discussing age-related findings from the HARMONi-6 trial.

HARMONi-6

06/21/2026

Age-Related Findings and Subgroup Analyses From the HARMONi-6 Trial

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Image from OncUpdates showing Dr. Bo Wang, Dr. Benjamin P. Levy, and Dr. Jarushka Naidoo discussing HARMONi-6 trial results.

HARMONi-6

06/20/2026

Follow-Up Duration and Survival Trends in the HARMONi-6 Trial

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Group photo of three doctors discussing HARMONi-6 as a new option for squamous NSCLC in a clinical setting.

HARMONi-6

06/19/2026

HARMONi-6 Generates Enthusiasm as a Potential New Option for Squamous NSCLC

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD
Image showing Dr. Bo Wang, Dr. Benjamin P. Levy, and Dr. Jarushka Naidoo discussing dual PD-1/VEGF blockade in squamous lung cancer research.

HARMONi-6

06/18/2026

Clinical Insights: The HARMONi-6 Trial and Dual PD-1/VEGF Blockade in Squamous Lung Cancer

Benjamin Levy, MDJarushka Naidoo, MB, BCh, MHSBo Wang, MD